Heparin protects BALB/c mice from mite-induced airway allergic inflammation

International Journal of Immunopathology and Pharmacology

Volumn 26, Issue 2, 2013, Pages 349-359

  Fu, L S ^a,b,c   Tsai, J J ^a   Chen, Y J ^a   Lin, H K ^a   Tsai, M C ^a   Chang, M D T ^d  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL CHI NAN UNIVERSITY   (Taiwan)

^d NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

Airway allergic inflammation; BALB c; Heparin; Mite

Indexed keywords

EOTAXIN; HEPARIN; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 5; INTERLEUKIN 8; ANTIBODY; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; LOW MOLECULAR WEIGHT HEPARIN;

AIRWAY RESISTANCE; ALLERGIC AIRWAY INFLAMMATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; EOSINOPHIL COUNT; GOBLET CELL; HISTOPATHOLOGY; LUNG LAVAGE; MALE; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; TREATMENT DURATION; ASTHMA; BLEEDING TIME; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; CELL HYPERPLASIA; CELL INFILTRATION; COMPARATIVE STUDY; DRUG EFFECT; IMMUNOGLOBULIN BLOOD LEVEL; LYMPHOCYTE COUNT; OPTICAL DENSITY; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; SENSITIZATION;

EID: 84881228868     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201302600208     Document Type: Article

References (32)

1. Weiler JM, Edens RE, Linhardt RJ, Kapelanski DP. Heparin and modified heparin inhibit complement activation in vivo. J Immunol 1992; 148:3210-15.
2. Wang L, Brown JR, Varki A, Esko JD. Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins. J Clin Invest 2001; 110:127-36. (Pubitemid 34743473)
3. Brwon RA, Lever R, Jones NA, Page CP. Effects of heparin and related molecules upon neutrophil aggregation and elastase release in vitro. Br J Pharmacol 2003; 139:845-53. (Pubitemid 36819612)
4. Thourani VH, Brarr SS, Kennedy TP, et al. Non-anticoagulant heparin inhibits NF-κB activation and attenuates myo-cardial reperfusion injury. Am J Physiol Heart Circ Physiol 2000; 278:H2084-H2093. (Pubitemid 30439223)
5. Celasco G, Papa A, Jones R, Moro L, Bozzella R, Surace MM, Naccari GC, Gasbarrini G. Clinical trial: oral colon-release parnaparin sodium tablets (CD-01-05 MMX) for active left-sided ulcerative colitis. Aliment Pharmacol Ther 2010; 31:375-86.
6. Peat JK, Tovey E, Toelle BG, Haby MM, Gray EJ, Mahmic A, Woolcock AJ. House dust mite allergens. A major risk factor for childhood asthma in Australia. Am J Respir Crit Care Med 1996; 153:141-46. (Pubitemid 26026840)
7. Giembycz MA, Lindsay MA. Pharmacology of the eosinophil. Pharmacol Rev 1999; 51:213-340.
8. Gleich GH. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 2000; 105:651-63.
9. Boyle JP, Smart RH, Shirey JK. Heparin in the treatment of chronic obstructive bronchopulmonary disease. Am J Cardiol 1964; 14:25-28.
10. Bardana EJ, Edwards MJ, Pirofsky B. Heparin as treatment for bronchospasm in asthma. Ann Allergy 1969; 27:108-13.
11. Ahmed T, Abraham WM, D'Brot J. Effects of inhaled heparin on immunologic and nonimmunologic bronchoconstrictor response in sheep. Am Rev Respir Dis 1992; 145:566-70.
12. Ahmed T, Garrigo J, Danta I. Preventing bronchoconstriction in exercise-induced asthma with inhaled heparin. N Engl J Med 1993; 329:90-95. (Pubitemid 23188822)
13. Garrigo J, Danta I, Ahmed T. Time course of the protective effect of inhaled heparin on exercise-induced asthma. Am J Respir Crit Care Med 1996; 153:1702-77.
14. Ford JG, Rennick D, Donaldson DD, et al. Il-13 and IFN-gamma: interactions in lung inflammation. J Immunol 2001; 167:1769-77. (Pubitemid 32703181)
15. Kashiwakura J, Okayama Y, Furue M, et al. Most highly cytokinergic IgEs have polyreactivity to autoantigens. Allergy Asthma Immunol Res 2012; 4:332-40.
16. Mondoulet L, Dioszeghy V, Ligouis M, Dhelft V, Dupont C, Benhamou PH. Epicutaneous immunotherapy on intact skin using a new delivery system in a murine model of allergy. Clin Exp Allergy 2010; 40:659-67.
17. Fan TC, Chang HT, Chen IW, Wang HY, Chang DTM. A heparan sulfate-facilitated and raft-dependent macropinocytosis of eosinophil cationic protein. Traffic 2007; 8:1778-95.
18. Clark K, Simson L, Newcombe N, et al. Eosinophil degranulation in the allergic lung of mice primarily occurs in the airway lumen. J Leukocyte Biol 2004; 75:1001-9. (Pubitemid 38720640)
19. Young E, Podor TJ, Venner T, Hirsh J. Induction of the acute-phase reaction increases heparin-binding proteins in plasma. Arterioscler Thromb Vasc Biol 1997; 17:1568-74. (Pubitemid 27387779)
20. Weiler JM, Edens RE, Lindhardt RJ, Kapelanski DP. Heparin and modified heparin inhibit complement activation in vivo. J Immunol 1992; 148:3210-15.
21. Moore KL, Patel KD, Bruehl RE, et al. P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin. J Cell Biol 1995; 128:661-71.
22. Diamond MS, Alon R, Parkos CA, Quinn MT, Springer TA. Heparin is an adhesive ligand for the leukocyte integrin Mac-1 (CD11b/CD18). J Cell Biol 1995; 130:1473-82.
23. Lin Y-Z, Yao SY, Veach RA, Torgerson TR, Hawiger J. Inhibition of nuclear translocation of transcription factor NF-κB by a synthetic peptide containing a cell membrane permeable motif and nuclear localization sequence. J Biol Chem 1995; 270:14255-58.
24. Young E. The anti-inflammatory effects of heparin and related compounds. Thrombosis Research 2008; 122:743-52.
25. Hellings PW, Kasran A, Liu Z, et al. Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. Am J Respir Cell Mol Biol 2003; 28:42-50. (Pubitemid 36017049)
26. Mukherjee S, Lindell DM, Berlin AA, Morris SB, Shanley TP, Hershenson MB, Lukacs NW. IL-17-induced pulmonary pathogenesis during respiratory viral infection and exacerbation of allergic disease. Am J Pathol 2011; 179:248-58.
27. Findelman FD, Hogan SP, Khurana Hershey GK, Rothenberg ME, Wills-Karp M. Importance of cytokines in murine allergic airway disease and human asthma. J Immunol 2010; 184:1663-74.
28. Doe C, Bafadhel M, Siddiqui S, et al. Expression of the T helper 17-associated cytokines IL-17A and IL-17F in asthma and COPD. Chest 2010; 138:1140-47.
29. Wilson RH, Whitehead GS, Nakano H, Free ME, Kills JK, Cook DN. Allergic sensitization through the airways primes Th17 dependent neutrophilia and airway hypreresponsiveness. Am J Respir Crit Care Med 2009; 180:720-30.
30. Park SJ, Lee YC. Interleukin-17 regulation: an attractive therapeutic approach for asthma. Respir Res 2010; 11:78.
31. Markart P, Nass R, Ruppert C, et al. Safety and tolerability of inhaled heparin in idiopathic pulmonary fibrosis. J Aerosol Med Pulm Drug Deliv 2010; 23:161-72.
32. Enkhbaatar P, Esechie A, Wang JP, et al. Combined anticoagulants ameliorate acute lung injury in sheep after burn and smoke inhalation. Clinical Science 2008; 114:321-29. (Pubitemid 351294008)